The Semi Contagion and the Energy Awakening

Market Regime

The VIX settled at 15.03 — a four-week low — masking a market that is increasingly bifurcated beneath the surface. The S&P 500 slipped 0.8% on July 13, but QQQ fell nearly 2%, while the Dow (flat) and small-caps (IWM -0.8%) held better. The yield curve remains positively steep at +36 bps, unemployment fell to 4.2%, and the dollar eased to 120.5 — a Goldilocks macro backdrop that is enabling aggressive sector rotation rather than driving risk-off. What we're witnessing is not a market top but a violent factor and sector repricing in real time.

Mega Forces

1. AI Capex Skepticism Infects the Semis. Last week's semi weakness was confined to optical and memory names (AAOI, MU). This week it broadened into the sacred cows. TSMC reported a 36% monthly sales jump — and the stock fell 2.9%. NVDA dropped 3.5%. INTC sank 6.1% after announcing a $5.7B Ireland expansion. The market is no longer rewarding capex announcements; it is questioning them. Rosenblatt notes that optical stocks (AAOI -37% in one month, COHR -13%) are being hit by CPO delay reports and China capacity scares. The "spend at all costs" narrative is giving way to "show us the revenue and margins." Meta's launch of Meta Compute — turning a CoreWeave customer into a direct competitor — only amplifies the concern that hyperscaler capex may consolidate into fewer, more vertically integrated winners.

2. The Hormuz Blockade Finally Hits Equities. Oil futures moved last week; energy stocks moved today. Refiners led the charge: VLO +5.4%, PSX +5.3%, MPC +4.6%, all with RSI pushing above 70. Producers followed: EOG +4.1%, CVX +3.3%, COP +3.5%. The key insight is the divergence: refiners are crushing it (wider crack spreads from supply disruption) while oil services (SLB -0.8%, HAL +2.4%) lag. This isn't a broad energy rally — it's a targeted repricing of downstream margins driven by a geopolitical tax on global crude flows. The Strait of Hormuz toll and Iranian port blockade are tangible policy actions, not just rhetoric.

3. Biotech Pulls Back — But the Rotation Isn't Over. After a breathtaking multi-week run (XBI +21% 1M, ARKG +24%), biotech took a breather today: XBI -2.3%, IBB -1.3%, BBIO -3.3%, ARKG -1.8%. This is textbook profit-taking in an extended move, not a reversal. The fundamental drivers remain intact: the Ionis/AZ failure (CARDIO-TTRansform) removed a competitive threat to BridgeBio's Attruby franchise; clinical catalysts continue (TRAX, KYMR); and M&A premium persists (CRNX/VRTX acquisition, Ligand/XOMA). Biotech themes occupy 7 of the top 10 performing themes in the past month.

What's Working

Refiners and energy infrastructure are the new leaders, driven by geopolitical supply disruption rather than demand. Financials continue their steady grind (+7.7% 1M, XLF RSI 68) with consolidation deals like First Hawaiian's $2B acquisition of TriCo (TCBK +12%) adding M&A fuel. Agriculture commodities (+5.3% 1M) are quietly outperforming as a diversifier. Fallen semi equipment may present a contrarian opportunity if the AI capex skepticism proves overdone, but the trend is firmly against that trade for now.

What to Avoid

Semiconductors broadly — the skepticism has spread beyond optical and memory to include the largest cap names. Avoid catching falling knives. Defense and space themes (-19% to -21% 1M) continue to deflate as the geopolitical premium rotates from defense stocks to energy stocks. Consumer discretionary sits below both its 50- and 150-day moving averages with negative 1M momentum. Autonomous vehicles and battery tech remain in the penalty box (-24% and -26% 1M respectively).

Strategy

The optimal positioning is a barbell: long energy refiners (geopolitical catalyst with tangible earnings impact), long financials (M&A supercycle + steepening yield curve), and selective biotech entry on this pullback (the secular rotation is intact but extended short-term). Reduce semi exposure into strength, and consider hedging tech-heavy portfolios. The market is not breaking down — it is rotating with conviction, and the reward goes to those who follow the capital flows rather than fight them.